The Serum coin (SRM) once sat at the center of Solana's decentralized trading dream — a slick on-chain order book that attracted billions in volume and the backing of some of crypto's loudest names. Then FTX and Alameda Research collapsed in November 2022, and SRM became one of the highest-profile casualties of the fiasco. The token's price cratered, the protocol froze, and the community was left asking a simple question: is Serum dead, or does it still have a pulse?

Fast-forward to today, and the answer is messier than a yes-or-no. A community-led fork called OpenBook has carried the open-order-book mantle forward, while the original SRM token still trades under a cloud of uncertainty. Understanding the full story matters whether you're holding bags, eyeing a rebound, or just trying to make sense of Solana's DeFi history.

What Exactly Is Serum Coin?

Serum was launched in 2020 as a non-custodial decentralized exchange built directly on Solana. Unlike the Automated Market Makers (AMMs) that dominated Ethereum DeFi at the time, Serum used a central limit order book running entirely on-chain. That meant traders could place limit orders, access deeper liquidity, and enjoy CEX-like speed — all without handing their funds to a centralized custodian. In a sea of AMMs, Serum's order-book model was a genuinely different pitch.

The native SRM token powered this ecosystem in several important ways:

  • Fee discounts on Serum-based trading pairs
  • Governance votes over protocol parameters and treasury spending
  • Staking rewards for users who locked up SRM to support liquidity
  • MEV rebates distributed back to stakers from protocol revenue

At its peak, Serum ranked among the top DEXes by volume on Solana, and SRM briefly sported a multi-billion-dollar market cap. The project was closely associated with Sam Bankman-Fried's orbit — a detail that would later prove catastrophic for its credibility.

The FTX Collapse and Its Aftermath

When FTX and Alameda imploded in late 2022, Serum's tight ties to those entities became a serious liability almost overnight. The DEX's upgrade keys — the keys that controlled protocol upgrades and treasury movements — were held by Alameda, and they effectively froze alongside FTX's bankruptcy proceedings. Within weeks, the Serum DAO voted to wind down the original program and effectively deprecate the v3 deployment.

For SRM holders, the damage was immediate and brutal:

  • The token shed roughly 90% of its value in the weeks surrounding the collapse
  • Liquidity on Serum-based markets dried up as market makers pulled back
  • Trust in the SRM brand collapsed along with FTX's reputation
  • Several projects that had integrated Serum quietly migrated to alternatives

Even the Serum Foundation itself tried to distance the project from SBF-era associations, reshuffling leadership and rebranding public-facing channels. But the stigma stuck, and SRM has never recovered anywhere close to its pre-collapse valuation.

The Birth of OpenBook

Out of the wreckage, a community fork called OpenBook emerged — a community-run version of Serum's order book, rebuilt without any ties to FTX or Alameda. OpenBook quickly became the default order-book venue for the Solana DeFi ecosystem, and many Solana apps that once relied on Serum pivoted to OpenBook seamlessly thanks to shared infrastructure.

OpenBook doesn't have a token tied to SRM, which has left a lot of legacy Serum holders frustrated. They backed the original protocol, took the hit, and now watch a new generation of traders use the technology without any of the upside.

Where Does SRM Stand Today?

Despite the turmoil, SRM is still tradable on a handful of centralized exchanges and on-chain venues. The token's utility is a shadow of its former self:

  • Trading-fee discounts on the original Serum UI still exist in a limited form
  • The Serum DAO technically continues to exist, though activity has slowed dramatically
  • Some smaller Solana projects still reference SRM in their staking or rewards programs

That's not nothing, but it's a far cry from the vibrant fee-revenue and governance machine that once made SRM a top-50 token. Most DeFi analysts now treat SRM as a high-risk speculative asset rather than a core Solana holding. If you're considering exposure, size it like a moonshot bet — not a core allocation.

Can Serum Make a Real Comeback?

A genuine SRM comeback would require at least three things: first, the FTX bankruptcy estate returning or releasing control of remaining Serum-related assets; second, fresh utility that gives SRM holders a reason to hold beyond speculation; and third, a clear separation between the SRM token and any lingering association with Alameda. Some community proposals have floated the idea of migrating SRM into the OpenBook ecosystem or merging governance rights, but none have gained serious traction so far.

For now, SRM trades more like a meme of Solana's past than a working piece of its future — a reminder of how fast things can fall apart when a DeFi protocol becomes entangled with a centralized empire. Whether that changes depends on whether the remaining community can summon the coordination and capital to make it happen.

Key Takeaways

  • Serum was Solana's flagship on-chain order-book DEX, launching in 2020 with the SRM token at its core
  • The FTX/Alameda collapse in 2022 froze the protocol and destroyed most of SRM's value and reputation
  • OpenBook now serves as the community fork carrying the order-book torch on Solana
  • SRM still trades, but its utility and developer activity are minimal compared to its peak
  • A real recovery would need fresh utility, clearer governance, and a clean break from the FTX-era baggage